24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release.
Saved in:
| Title: | 24-Hour Induction of Transdermal Buprenorphine to Buprenorphine Extended-Release. |
|---|---|
| Authors: | Azar P; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Li VW; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Wong JSH; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Nikoo M; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Machado J; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada., Ignaszewski MJ; Integrated Psychiatry, Pain, and Addiction Service, Vancouver General Hospital, Vancouver, BC, Canada.; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; Substance Use Response and Facilitation Service, BC Children's Hospital, Provincial Health Services Authority, BC, Canada., Mathew N; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.; BC Mental Health & Substance Use Services, Provincial Health Services Authority, BC, Canada., Raheemullah A; Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, USA., Wakeman SE; Department of Medicine, Massachusetts General Hospital, Boston, USA.; Department of Medicine, Harvard Medical School, Boston, USA., Mullen R; The C4 Foundation, Coronado, CA, USA., Krausz RM; Addictions and Concurrent Disorders Research Group, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Montaner JSG; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada., Maharaj AR; Pharmacokinetics Modeling and Simulation Laboratory, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. |
| Source: | Journal of psychoactive drugs [J Psychoactive Drugs] 2026 Apr-Jun; Vol. 58 (2), pp. 166-170. Date of Electronic Publication: 2024 Nov 19. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8113536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-9777 (Electronic) Linking ISSN: 02791072 NLM ISO Abbreviation: J Psychoactive Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2159-9777 |
|---|---|
| DOI: | 10.1080/02791072.2024.2430616 |
